A fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effects

dc.article.end-page32en
dc.article.start-page1en
dc.citation.doi10.1038/S41598-024-66531-Xen
dc.contributor.authorD Amiloen
dc.contributor.authorChinedu Izuchukwuen
dc.contributor.authorK Sadrien
dc.contributor.authorHao-Ren Yaoen
dc.contributor.authorE Hincalen
dc.contributor.authorY Shehuen
dc.date.accessioned2024-09-16T13:18:57Z
dc.date.available2024-09-16T13:18:57Z
dc.facultyFACULTY OF SCIENCEen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/40839
dc.journal.titleA fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effectsen
dc.journal.volume14en
dc.school5.06en
dc.titleA fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effectsen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
2.95 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client